To verify that the atherosclerosis-stimulating effect associated with T0901317 treatment was not dependent on a specific anatomical location, we also quantified the gene expression levels of the macrophage marker CD68 within the aortic arches of the different mice as surrogate measure for the aortic atherosclerotic lesion burden. The gene discussed is CD68; the disease is atherosclerosis.